All In MedTech

FDA Clearance Tracker · P150009

Guardian System

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Apr 9, 2018 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Apr 9, 2018

Approved

Time to decision

1,141 days

Received Feb 23, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P150009
Device name
Guardian System
Applicant location
North Palm Beach, FL
Received
Feb 23, 2015
Decided
Apr 9, 2018
Decision
Approved
Supplements
12 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code QBI

FDA's approval statement

As written in FDA's record.

Approval of the AngelMed Guardian System. This device is indicated for use in patients who have had prior acute coronary syndrome (ACS) events and who remain at high risk for recurrent ACS events.The Guardian System is indicated as an adjunct to patient recognized symptoms. The Guardian System detects potential ongoing ACS events, characterized by sustained ST segment changes, and alerts the patient to seek medical attention for those potential ACS events. A Guardian System alert is a more accurate predictor of ACS events when compared to patient recognized symptoms alone and demonstrates a reduced rate over time of patient presentations without ACS events (false positives) when compared to patient recognized symptoms alone. In the absence of symptoms, the Guardian System may identify asymptomatic ACS events and prompt the patient to seek medical attention.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code QBI (Acute coronary syndrome event detector).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for CJ Healthtech Holdings, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.